Mineola, New York — Mineola, New York

Mineola, New York is a clinical research site located in Mineola, New York, United States 11501.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Mineola, New York has participated in 1 clinical trials.

Therapeutic areas: Seizures.

Sponsors: AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Mineola

Browse all research sites in New York · View every site in Mineola

• New York University (NYU) Langone Hospital Long Island
• Winthrop University Dialysis Center
• Withrop University Hospital
• NYU Langone Hospital - Long Island /ID# 265531
• NYU Langone Hospital - Long Island-Pediatrics ( Site 0028)
• Winthrop-University Hospital Program
• New York University Langone Long Island
• Winthorp University Hospital
• NYU Long Island Hospital
• NYU Winthrop Hospital, Clinical Trials Center
• Winthrop University Hospital Outpatient Dialysis Unit
• NYU Langone Health Hospital Long Island

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mineola, New York?

Mineola, New York has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mineola, New York conducted?

Mineola, New York has 1 clinical trials on record. Their work covers Seizures.

Is Mineola, New York accredited by Crixeo Clinical Trials?

Mineola, New York has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mineola, New York?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.